Dhivy

Generic name:carbidopa levodopa
Dosage form: tablet
Drug class:Dopaminergic antiparkinsonism agents

Medically reviewed by Drugs.com. Last updated on Feb 1, 2022.

Indications and Usage for Dhivy

Dhivy is indicated for the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Dhivy Dosage and Administration

2.1 Initial Dosage and Maintenance of Therapy

The recommended starting dosage of Dhivy is one 25 mg / 100 mg tablet taken orally three times a day. This dosage schedule provides 75 mg of carbidopa per day. Dosage may be increased by up to one whole tablet every day or every other day, as needed to a maximum daily dosage of eight whole tablets.

Dosing with Dhivy should be individualized and adjusted according to clinical response and tolerability. The tablet is functionally scored to facilitate dose adjustment. At least 70 mg to 100 mg of carbidopa per day should be provided. Experience with total daily dosages of carbidopa greater than 200 mg is limited.

Monitor patients closely during the dose adjustment period. Specifically, involuntary movements may occur with Dhivy, which may require dosage reduction. Blepharospasm may be a useful early sign of excess dosage in some patients.

Maintain patients on the lowest dosage required to achieve symptomatic control and to minimize adverse reactions, such as dyskinesia and nausea.

2.2 Discontinuation of Dhivy

Avoid sudden discontinuation or rapid dose reduction of Dhivy. The daily dosage of Dhivy should be tapered at the time of treatment discontinuation [seeWarnings and Precautions (5.2)].

If general anesthesia is required, Dhivy may be continued as long as the patient is permitted to take fluids and medication by mouth. If therapy is interrupted temporarily, the patient sho...